BioGaia AB (FRA:BGLA)

€ 9.025 -0.055 (-0.61%) Market Cap: 927.89 Mil Enterprise Value: 831.44 Mil PE Ratio: 31.83 PB Ratio: 6.64 GF Score: 95/100

Q3 2024 Biogaia AB Earnings Call Transcript
Oct 22, 2024

€8.57 (-0.06%)

Earnings
Q2 2024 Biogaia AB Earnings Call Transcript
Jul 23, 2024

€10.72 (+1.80%)

Earnings
Q4 2023 Biogaia AB Earnings Call Transcript
Feb 07, 2024

€10.85 (+11.86%)

Earnings
Q3 2023 Biogaia AB Earnings Call Transcript
Oct 20, 2023

€8.4 (-1.52%)

Earnings
Q2 2023 Biogaia AB Earnings Call Transcript
Jul 21, 2023

€8.92 (+0.85%)

Earnings
Q1 2023 Biogaia AB Earnings Call Transcript
May 05, 2023

€9.12 (-0.82%)

Earnings
Q4 2022 Biogaia AB Earnings Call Transcript
Feb 03, 2023

€8.64 (+4.60%)

Earnings
Q3 2022 Biogaia AB Earnings Call Transcript
Oct 21, 2022

€7.82 (-1.70%)

Earnings
Q2 2022 Biogaia AB Earnings Call Transcript
Jul 22, 2022

€10.7 (+0.94%)

Earnings
Q1 2022 Biogaia AB Interim Management Statement Call Transcript
May 06, 2022
Q4 2021 Biogaia AB Earnings Call Transcript
Feb 04, 2022

€9.34 (-1.37%)

Earnings
Q3 2021 Biogaia AB Interim Management Statement Call Transcript
Oct 21, 2021
Q2 2021 Biogaia AB Earnings Call Transcript
Aug 12, 2021

€9.58 (-4.39%)

Earnings
Q1 2021 Biogaia AB Interim Management Statement Call Transcript
May 06, 2021
Q4 2020 Biogaia AB Earnings Call Transcript
Feb 04, 2021

€8.88 (-5.03%)

Earnings
Q3 2020 Biogaia AB Earnings Call Transcript
Oct 23, 2020

€8.84 (+1.84%)

Earnings
Q2 2020 Biogaia AB Earnings Call Transcript
Aug 13, 2020

€10.84 (+0.74%)

Earnings
Q1 2020 Biogaia AB Earnings Call Transcript
May 07, 2020

€9.01 (-1.31%)

Earnings
Q4 2019 Biogaia AB Earnings Call Transcript
Feb 06, 2020

€8.15 (+1.24%)

Earnings
Q3 2019 Biogaia AB Earnings Call Transcript
Oct 23, 2019

€7.1 (-1.39%)

Earnings
Q2 2019 Biogaia AB Earnings Call Transcript
Aug 08, 2019

€7.09 (-3.54%)

Earnings
Q1 2019 Biogaia AB Earnings Call Transcript
May 08, 2019

€8.39 (-0.24%)

Earnings

Q1 2019 Biogaia AB Earnings Call Transcript

May 08, 2019 / 07:30AM GMT

Release Date Price: €8.39 (-0.24%)

Transcript

Operator

Ladies and gentlemen. Welcome to the BioGaia Q1 report 2019. Today, I'm pleased to present Isabelle Ducellier, CEO; and Margareta Hagman, CFO. (Operator Instructions) Speakers, please begin.

Isabelle Valerie Ghislaine Ducellier;publ;CEO

BioGaia AB

()-

Yes, good morning and thank you. Isabelle here. Welcome to my second telephone conference, but this time regarding the quarter 1 2019.

I would like to underline 4 dimensions regarding this quarter. Next slide, please. The first one is that we have actually strong sales growth of our products in both Pediatrics and Adult segment. And especially in Adult segment, we have an increase by 54%.

Secondly, I would like as well to emphasize strong sales growth for BioGaia Protectis drops; BioGaia Protectis tablets, which is quite unusual, so it's worth mentioning it; and BioGaia Prodentis lozenges mainly driven by Japan.

Thirdly, I think it is very worth noticing that we have extremely strong growth in the Asia Pacific region, with Quarter 1 at plus 80%. And

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.